Use of Bortezomib in recurrent and refractory multiple myeloma and impaired renal function

被引：0
|
作者：
Falcone, A. [1 ]
Sanpaolo, G. [1 ]
Bodenizza, C. [1 ]
Carella, A. M. [1 ]
Dell'Olio, M. [1 ]
Mantuano, S. [1 ]
Melillo, L. [1 ]
Merla, E. [1 ]
Scalzulli, F. [1 ]
Cascavilla, N. [1 ]
机构：
[1] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
  • [31] Economic evaluation of bortezomib (VELCADE) for relapsed and refractory multiple myeloma
    Bagust, A
    Haycox, AR
    Boland, A
    Chu, P
    Morgan, GJ
    Mota, REM
    Dubois, D
    Dhawan, R
    BLOOD, 2004, 104 (11) : 80A - 80A
  • [32] EFFECTS OF BORTEZOMIB ON RENAL IMPAIRMENT MULTIPLE MYELOMA PATIENTS
    Chen, W.
    Lu, J.
    Hou, J.
    HAEMATOLOGICA, 2013, 98 : 340 - 341
  • [33] Strategies in the treatment of recurrent refractory multiple myeloma
    Goldschmidt, H.
    Raab, M. -S.
    Neben, K.
    Weisel, K.
    Schmidt-Wolf, I. G. H.
    ONKOLOGE, 2014, 20 (03): : 250 - 256
  • [34] Sorafenib in patients with refractory or recurrent multiple myeloma
    Yordanova, Anna
    Hose, Dirk
    Neben, Kai
    Witzens-Harig, Mathias
    Guetgemann, Ines
    Raab, Marc-Steffen
    Moehler, Thomas
    Goldschmidt, Hartmut
    Schmidt-Wolf, Ingo G. H.
    HEMATOLOGICAL ONCOLOGY, 2013, 31 (04) : 197 - 200
  • [35] Impaired NHEJ function in multiple myeloma
    Yang, Clara
    Betti, Christopher
    Singh, Sheetal
    Toor, Amir
    Vaughan, Andrew
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2009, 660 (1-2) : 66 - 73
  • [36] EFFECTIVENESS OF BORTEZOMIB AND BORTEZOMIB-CONTAINING PROGRAMS FOR THE TREATMENT OF RECURRENT AND RESISTANT MULTIPLE MYELOMA
    Mitina, T. A.
    Golenkov, A. K.
    Katayeva, E. V.
    Lutskaya, T. D.
    Trifonona, E. V.
    Klinushkina, E. F.
    TERAPEVTICHESKII ARKHIV, 2010, 82 (07) : 57 - 61
  • [37] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
  • [38] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [39] RENAL FUNCTION IN MULTIPLE MYELOMA
    ARMSTRONG, JB
    JOURNAL OF CLINICAL INVESTIGATION, 1949, 28 (04): : 768 - 768
  • [40] RENAL FUNCTION IN MULTIPLE MYELOMA
    GOLDMAN, R
    ADAMS, WS
    LUCHSINGER, EB
    JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1952, 40 (04): : 519 - 522
12345